BIOARDIS
BioArdis provides their services on value creation through efficient small molecule drug discovery; perfecting the process from lead to preclinical development candidate. They are motivated by science, so they are not focused on any particular therapeutic area. Through top-tier executive and advisory teams, they develop a pipeline of internal and partnered programs with the goal of delivering PDCs in timeframes and at costs not achieved previously. Through critical relationships with preferred research partners, they will continue to expand their pipeline to routinely deliver both first-in-class and best-in-class products.
BIOARDIS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.bioardis.com
Status:
Active
Contact:
+1 858 412 2027
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Domain Not Resolving
Current Employees Featured
Founder
Official Site Inspections
http://www.bioardis.com
- Host name: 191.0.153.160.host.secureserver.net
- IP address: 160.153.0.191
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "BioArdis"
BioArdis - Crunchbase Company Profile & Funding
BioArdis provides their services on value creation through efficient small molecule drug discovery; perfecting the process from lead to preclinical development candidate. They are motivated by …See details»
BioArdis - LinkedIn
BioArdis is an innovative therapeutic development company with a pipeline of oncology and immuno-oncology drug candidates, and a novel chimeric antigen receptor T cell (“CAR-T”) platform with ...See details»
BioArdis Company Profile | Management and Employees List
BioArdis Profile and History. BioArdis LLC, founded in 2017 with operations in San Diego and Shanghai, is a biopharmaceutical company that strives to discover and develop life-changing …See details»
BioArdis Company Profile 2024: Valuation, Funding & Investors
BioArdis General Information Description. Operator of a pre-clinical biopharmaceutical development company intended to provide validated programs ready to advance into clinical …See details»
Our Portfolio - BioArdis
BioArdis’s CAR-T platform is powered by a proprietary and highly differentiated large-scale screening engine that begins with target tumor antigen selection and optimizes key elements …See details»
BioArdis - Overview, News & Similar companies | ZoomInfo.com
Apr 2, 2020 BioArdis LLC, founded in 2017 with operations in San Diego and Shanghai, is a biopharmaceutical company that strives to discover and develop life-c hanging medicines for …See details»
BioArdis LLC - Drug pipelines, Patents, Clinical trials - Synapse
Last update 01 Nov 2024. BioArdis LLC. Private Company |See details»
BioArdis - Products, Competitors, Financials, Employees, …
BioArdis is an innovative therapeutic development company focused on oncology and immuno-oncology drug candidates. The company offers a range of small molecule therapies for …See details»
BioArdis names Kedar Muley Chief Business Officer, acting CEO
May 4, 2021 "BioArdis has been very proficient in developing a deep pipeline of best-in-class small molecule therapies and a cell therapy discovery engine that has generated multiple …See details»
BioArdis - VentureRadar
" BioArdis is an innovative therapeutic development company with a pipeline of oncology and immuno-oncology drug candidates, and a novel chimeric antigen receptor T cell (“CAR-T”) …See details»
BioArdis - Company Profile - Tracxn
Nov 5, 2024 BioArdis ranks 487th among 641 active competitors. 237 of its competitors are funded while 153 have exited. Overall, BioArdis and its competitors have raised over $27.6B in …See details»
Shenogen enters into an Exclusive License with BioArdis to …
Apr 3, 2020 BioArdis LLC, founded in 2017 with operations in San Diego and Shanghai, is a biopharmaceutical company that strives to discover and develop life-changing medicines for …See details»
BioArdis - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. BioArdis . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 5. ... BioArdis is actively using 5 …See details»
Shenogen enters into an Exclusive License with BioArdis to …
Shenogen, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients …See details»
MRGPRX2 Antagonist(BioArdis) - Drug Targets, Indications, …
Nov 21, 2024 MRGPRX2 Antagonist(BioArdis): a MRGPRX2 antagonists Drug, Initially developed by BioArdis LLC, Now, its global highest R&D status is Preclinical, Mechanism: …See details»
Shenogen enters into an exclusive license with BioArdis to develop …
BioArdis will retain all rights to the licensed product in the rest of the world. BIO-1262 is being evaluated as a potential new treatment for hepatocellular carcinoma (HCC) and other solid …See details»
Shenogen enters into an Exclusive License with BioArdis to
Apr 3, 2020 BEIJING and SHANGHAI and SAN DIEGO, April 3, 2020 /PRNewswire/ -- Shenogen, a biopharmaceutical company focused on developing and commercializing …See details»
BioArdis and Shenogen to develop commercialize novel FGFR4
BioArdis will retain all rights to the licensed product in the rest of the world. BIO-1262 is being evaluated as a potential new treatment for hepatocellular carcinoma (HCC) and other solid …See details»
Research programme: FGFR 2/3 Inhibitor therapeutics - BioArdis
11 Jan 2023 Early research in Cancer in USA (unspecified route) (before January 2023) (BioArdis Pipeline, January 2023) You need to be a logged in or subscribed to view this content Request …See details»